Calcineurin activation causes retinal ganglion cell degeneration

Juan Qu, Roland Matsouaka, Rebecca Betensky, Bradley T. Hyman, Cynthia L. Grosskreutz

Research output: Contribution to journalArticle

Abstract

Purpose: We previously reported that calcineurin, a Ca2+/calmodulin-dependent serine/threonine phosphatase, is activated and proposed that it participates in retinal ganglion cell (RGC) apoptosis in two rodent ocular hypertension models. In this study, we tested whether calcineurin activation by itself, even in the absence of ocular hypertension, is sufficient to cause RGC degeneration. Methods: We compared RGC and optic nerve morphology after adeno-associated virus serotype 2 (AAV2)-mediated transduction of RGCs with constitutively active calcineurin (CaNCA) or unactivated, wild-type calcineurin (CaNwt). Retinas and optic nerves were harvested 7-16 weeks after injection of the AAV into mouse vitreous. In flatmounted retinas, the transduced RGCs were identified with immunohistochemistry. The morphology of the RGCs was revealed by immunostaining for neurofilament SMI32 or by using GFP-M transgenic mice. A modified Sholl analysis was applied to analyze the RGC dendritic morphology. Optic nerve damage was assessed with optic nerve grading according to the Morrison standard. Results: CaNwt and CaNCA were highly expressed in the injected eyes. Compared to the CaNwt-expressing RGCs, the CaNCA-expressing RGCs had smaller somas, smaller dendritic field areas, shorter total dendrite lengths, and simpler dendritic branching patterns. At 16 weeks, the CaNCA-expressing eyes had greater optic nerve damage than the CaNwt-expressing eyes. Conclusions: Calcineurin activation is sufficient to cause RGC dendritic degeneration and optic nerve damage. These data support the hypothesis that calcineurin activation is an important mediator of RGC degeneration, and are consistent with the hypothesis that calcineurin activation may contribute to RGC neurodegeneration in glaucoma.

Original languageEnglish (US)
Pages (from-to)2828-2838
Number of pages11
JournalMolecular Vision
Volume18
StatePublished - Nov 29 2012

Fingerprint

Retinal Ganglion Cells
Calcineurin
Optic Nerve
Ocular Hypertension
Retina
Dependovirus
Intermediate Filaments
Phosphoprotein Phosphatases
Carisoprodol
Calmodulin
Dendrites
Glaucoma
Transgenic Mice
Rodentia
Immunohistochemistry
Apoptosis
Injections

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Qu, J., Matsouaka, R., Betensky, R., Hyman, B. T., & Grosskreutz, C. L. (2012). Calcineurin activation causes retinal ganglion cell degeneration. Molecular Vision, 18, 2828-2838.

Calcineurin activation causes retinal ganglion cell degeneration. / Qu, Juan; Matsouaka, Roland; Betensky, Rebecca; Hyman, Bradley T.; Grosskreutz, Cynthia L.

In: Molecular Vision, Vol. 18, 29.11.2012, p. 2828-2838.

Research output: Contribution to journalArticle

Qu, J, Matsouaka, R, Betensky, R, Hyman, BT & Grosskreutz, CL 2012, 'Calcineurin activation causes retinal ganglion cell degeneration', Molecular Vision, vol. 18, pp. 2828-2838.
Qu J, Matsouaka R, Betensky R, Hyman BT, Grosskreutz CL. Calcineurin activation causes retinal ganglion cell degeneration. Molecular Vision. 2012 Nov 29;18:2828-2838.
Qu, Juan ; Matsouaka, Roland ; Betensky, Rebecca ; Hyman, Bradley T. ; Grosskreutz, Cynthia L. / Calcineurin activation causes retinal ganglion cell degeneration. In: Molecular Vision. 2012 ; Vol. 18. pp. 2828-2838.
@article{674862dd2a9f429a9cd215b43a5823c9,
title = "Calcineurin activation causes retinal ganglion cell degeneration",
abstract = "Purpose: We previously reported that calcineurin, a Ca2+/calmodulin-dependent serine/threonine phosphatase, is activated and proposed that it participates in retinal ganglion cell (RGC) apoptosis in two rodent ocular hypertension models. In this study, we tested whether calcineurin activation by itself, even in the absence of ocular hypertension, is sufficient to cause RGC degeneration. Methods: We compared RGC and optic nerve morphology after adeno-associated virus serotype 2 (AAV2)-mediated transduction of RGCs with constitutively active calcineurin (CaNCA) or unactivated, wild-type calcineurin (CaNwt). Retinas and optic nerves were harvested 7-16 weeks after injection of the AAV into mouse vitreous. In flatmounted retinas, the transduced RGCs were identified with immunohistochemistry. The morphology of the RGCs was revealed by immunostaining for neurofilament SMI32 or by using GFP-M transgenic mice. A modified Sholl analysis was applied to analyze the RGC dendritic morphology. Optic nerve damage was assessed with optic nerve grading according to the Morrison standard. Results: CaNwt and CaNCA were highly expressed in the injected eyes. Compared to the CaNwt-expressing RGCs, the CaNCA-expressing RGCs had smaller somas, smaller dendritic field areas, shorter total dendrite lengths, and simpler dendritic branching patterns. At 16 weeks, the CaNCA-expressing eyes had greater optic nerve damage than the CaNwt-expressing eyes. Conclusions: Calcineurin activation is sufficient to cause RGC dendritic degeneration and optic nerve damage. These data support the hypothesis that calcineurin activation is an important mediator of RGC degeneration, and are consistent with the hypothesis that calcineurin activation may contribute to RGC neurodegeneration in glaucoma.",
author = "Juan Qu and Roland Matsouaka and Rebecca Betensky and Hyman, {Bradley T.} and Grosskreutz, {Cynthia L.}",
year = "2012",
month = "11",
day = "29",
language = "English (US)",
volume = "18",
pages = "2828--2838",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Calcineurin activation causes retinal ganglion cell degeneration

AU - Qu, Juan

AU - Matsouaka, Roland

AU - Betensky, Rebecca

AU - Hyman, Bradley T.

AU - Grosskreutz, Cynthia L.

PY - 2012/11/29

Y1 - 2012/11/29

N2 - Purpose: We previously reported that calcineurin, a Ca2+/calmodulin-dependent serine/threonine phosphatase, is activated and proposed that it participates in retinal ganglion cell (RGC) apoptosis in two rodent ocular hypertension models. In this study, we tested whether calcineurin activation by itself, even in the absence of ocular hypertension, is sufficient to cause RGC degeneration. Methods: We compared RGC and optic nerve morphology after adeno-associated virus serotype 2 (AAV2)-mediated transduction of RGCs with constitutively active calcineurin (CaNCA) or unactivated, wild-type calcineurin (CaNwt). Retinas and optic nerves were harvested 7-16 weeks after injection of the AAV into mouse vitreous. In flatmounted retinas, the transduced RGCs were identified with immunohistochemistry. The morphology of the RGCs was revealed by immunostaining for neurofilament SMI32 or by using GFP-M transgenic mice. A modified Sholl analysis was applied to analyze the RGC dendritic morphology. Optic nerve damage was assessed with optic nerve grading according to the Morrison standard. Results: CaNwt and CaNCA were highly expressed in the injected eyes. Compared to the CaNwt-expressing RGCs, the CaNCA-expressing RGCs had smaller somas, smaller dendritic field areas, shorter total dendrite lengths, and simpler dendritic branching patterns. At 16 weeks, the CaNCA-expressing eyes had greater optic nerve damage than the CaNwt-expressing eyes. Conclusions: Calcineurin activation is sufficient to cause RGC dendritic degeneration and optic nerve damage. These data support the hypothesis that calcineurin activation is an important mediator of RGC degeneration, and are consistent with the hypothesis that calcineurin activation may contribute to RGC neurodegeneration in glaucoma.

AB - Purpose: We previously reported that calcineurin, a Ca2+/calmodulin-dependent serine/threonine phosphatase, is activated and proposed that it participates in retinal ganglion cell (RGC) apoptosis in two rodent ocular hypertension models. In this study, we tested whether calcineurin activation by itself, even in the absence of ocular hypertension, is sufficient to cause RGC degeneration. Methods: We compared RGC and optic nerve morphology after adeno-associated virus serotype 2 (AAV2)-mediated transduction of RGCs with constitutively active calcineurin (CaNCA) or unactivated, wild-type calcineurin (CaNwt). Retinas and optic nerves were harvested 7-16 weeks after injection of the AAV into mouse vitreous. In flatmounted retinas, the transduced RGCs were identified with immunohistochemistry. The morphology of the RGCs was revealed by immunostaining for neurofilament SMI32 or by using GFP-M transgenic mice. A modified Sholl analysis was applied to analyze the RGC dendritic morphology. Optic nerve damage was assessed with optic nerve grading according to the Morrison standard. Results: CaNwt and CaNCA were highly expressed in the injected eyes. Compared to the CaNwt-expressing RGCs, the CaNCA-expressing RGCs had smaller somas, smaller dendritic field areas, shorter total dendrite lengths, and simpler dendritic branching patterns. At 16 weeks, the CaNCA-expressing eyes had greater optic nerve damage than the CaNwt-expressing eyes. Conclusions: Calcineurin activation is sufficient to cause RGC dendritic degeneration and optic nerve damage. These data support the hypothesis that calcineurin activation is an important mediator of RGC degeneration, and are consistent with the hypothesis that calcineurin activation may contribute to RGC neurodegeneration in glaucoma.

UR - http://www.scopus.com/inward/record.url?scp=84871091364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871091364&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 2828

EP - 2838

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -